UNSPSC 51291805: Eclanamine maleate

This classification denotes an antidepressant agent with the molecular formula C16H22CL2N2O.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J2C169J769. The term eclanamine maleate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule eclanamine maleate under HS 29242995 and SITC 51479. As of Q4 2014, ECLANAMINE MALEATE remains US FDA's Preferred Term for this commodity. Eclanamine maleate bears US NLM identifiers UMLS ID C0957739 and NCI Concept Code C75171.

SMILES: CCC(=O)N(C1CCC(C(C1)CL)CL)[C@@H]2CCC[C@H]2N(C)C.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51291805 Eclanamine maleate (Commodity) represents pharmaceutical products procured by state and local health and emergency-response agencies, though the recent solicitation activity under this code reflects a mismatch between the code's nominal scope and actual buying patterns. Seminole County, Florida posted an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually—products that fall outside eclanamine maleate's chemical scope and instead represent opioid-reversal and drug-disposal equipment. The county's procurement targets community health initiatives with quarterly deliveries to its Community Health Building in Sanford, Florida, and includes standard state and local requirements: electronic bid submission, drug-free workplace certification, E-Verify compliance, workers' compensation and general-liability insurance, and a three-month probationary termination clause. The contract structure carries a two-year initial term with a one-year renewal option, and potential FEMA funding introduces federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence.

The code shows minimal recent activity directly aligned with its pharmaceutical commodity definition. The single tracked opportunity—Seminole County's naloxone procurement (IFB 60459723LAS, response deadline July 26, 2023)—represents a categorization anomaly rather than a typical eclanamine maleate purchase. Geographic coverage in the recent record is limited to Florida. Prospective bidders should verify whether this UNSPSC assignment reflects a data-entry error in the county's e-Procurement Portal or a legitimate product cross-listing before investing in pursuit; the work being solicited deviates substantially from the code's pharmaceutical classification.